VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $649,000 | -39.1% | 3,640 | -24.2% | 0.06% | -4.8% |
| Q2 2015 | $1,066,000 | +3.2% | 4,800 | -7.7% | 0.06% | -6.0% |
| Q1 2015 | $1,033,000 | +55.6% | 5,200 | +12.1% | 0.07% | +52.3% |
| Q4 2014 | $664,000 | +4.7% | 4,640 | -3.9% | 0.04% | 0.0% |
| Q3 2014 | $634,000 | -48.7% | 4,830 | -50.7% | 0.04% | -48.2% |
| Q2 2014 | $1,235,000 | -88.8% | 9,795 | -88.3% | 0.08% | -89.5% |
| Q1 2014 | $11,075,000 | -4.1% | 84,011 | -14.6% | 0.81% | -5.8% |
| Q4 2013 | $11,549,000 | +22.0% | 98,376 | +8.4% | 0.86% | +10.7% |
| Q3 2013 | $9,465,000 | -9.3% | 90,726 | -25.2% | 0.78% | -15.7% |
| Q2 2013 | $10,439,000 | – | 121,276 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |